Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers

Clinical trial NCT04415671 · COMPLETED

Trial details

NCT number: NCT04415671
Sponsor: AdAlta Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Interstitial Lung Disease

Start date: 2020-06-19
Primary completion: 2021-10-21
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.